Literature DB >> 3121159

Protection against Pseudomonas aeruginosa infection by passive transfer of anti-flagellar serum.

D Drake1, T C Montie.   

Abstract

The specificity of adsorbed flagellar antisera for H-antigen was demonstrated in vitro by cross-agglutination assays, motility inhibition, and an ELISA. The specific flagellar antibody was determined to be an IgG. Complete protection against burn wound sepsis was achieved with flagellar antisera. Cross-protection experiments revealed that protection was not only H-antigen dependent, but specific for the flagella antigen type. Antiserum raised against b-type flagella would only protect against homologous bacterial challenge and not against a-type flagellated strains. Results using a-type antisera were consistent, giving protection only against the homologous strain. In contrast, protective capacity was selectively removed from antisera by adsorbing with Fla+ cells. Bacteria colonized the burn wounds of passively protected mice to similar levels as seen in nonprotected animals, but the colonization remained localized and did not result in systemic infection, a pattern similar to infections with motility mutants observed in other studies. Animals rendered neutropenic prior to burning were not protected with flagellar antisera. These data suggested a role for phagocytic cells in protection. Immobilization by flagellar antiserum was observed both by microscopic studies and by inhibition of colony spreading. Antiflagellar antibody is hypothesized as exerting its protective capacity possibly in two ways; first by inhibiting the motility of invading bacteria by binding to the flagellum and immobilizing the bacteria, and secondly by acting as an opsonin, targeting either immobilized or mobile cells for phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121159     DOI: 10.1139/m87-130

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  17 in total

1.  Phosphorylated tyrosine in the flagellum filament protein of Pseudomonas aeruginosa.

Authors:  K Kelly-Wintenberg; T Anderson; T C Montie
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

2.  Immunological considerations in the development of Pseudomonas aeruginosa vaccines.

Authors:  Sarah M Baker; James B McLachlan; Lisa A Morici
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

3.  Effect of antiflagellar human monoclonal antibody on gut-derived Pseudomonas aeruginosa sepsis in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

4.  Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines.

Authors:  Victoria L Campodónico; Nicolás J Llosa; Martha Grout; Gerd Döring; Tomás Maira-Litrán; Gerald B Pier
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

5.  Cloning and expression of Pseudomonas aeruginosa flagellin in Escherichia coli.

Authors:  K Kelly-Wintenberg; T C Montie
Journal:  J Bacteriol       Date:  1989-11       Impact factor: 3.490

6.  Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.

Authors:  T R Anderson; T C Montie; M D Murphy; V P McCarthy
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

7.  Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin.

Authors:  G Molinari; P Paglia; G C Schito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

8.  Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models.

Authors:  K Richardson
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

9.  Therapeutic effects of a human antiflagella monoclonal antibody in a neutropenic murine model of Pseudomonas aeruginosa pneumonia.

Authors:  K Oishi; F Sonoda; A Iwagaki; P Ponglertnapagorn; K Watanabe; T Nagatake; A Siadak; M Pollack; K Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  Inhibitory activity on bacterial motility and in vivo protective activity of human monoclonal antibodies against flagella of Pseudomonas aeruginosa.

Authors:  H Ochi; H Ohtsuka; S Yokota; I Uezumi; M Terashima; K Irie; H Noguchi
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.